Sulodexide in the Treatment of Early Stages of COVID-19
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Sulodexide (Primary)
- Indications COVID 2019 infections; Thromboembolism
- Focus Therapeutic Use
- Acronyms SulES-COVID
- 07 Sep 2020 Status changed from active, no longer recruiting to completed.
- 03 Sep 2020 Planned End Date changed from 10 Aug 2020 to 27 Aug 2020.
- 03 Sep 2020 Status changed from recruiting to active, no longer recruiting.